Detalhe da pesquisa
1.
Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancer.
Ann Oncol
; 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38777726
2.
Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142.
Ann Oncol
; 33(10): 1052-1060, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35764271
3.
JSCO-ESMO-ASCO-JSMO-TOS: international expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions.
Ann Oncol
; 31(7): 861-872, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32272210
4.
Defining the subset of mutations in Polymerase Epsilon (POLE) associated with Loss-of-Proofreading (LOP) functionality.
Ann Oncol
; 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38734075
5.
Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challenge.
Ann Oncol
; 30(2): 243-249, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30462160
6.
Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer.
Ann Oncol
; 29(1): 139-144, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29069279
7.
High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients.
Ann Oncol
; 28(4): 741-747, 2017 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28104621
8.
Utility of a molecular prescreening program in advanced colorectal cancer for enrollment on biomarker-selected clinical trials.
Ann Oncol
; 27(6): 1068-1074, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27045102
9.
Validation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma.
Br J Cancer
; 113(1): 64-8, 2015 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-25989273
10.
Association between KRAS mutation and lung metastasis in advanced colorectal cancer.
Br J Cancer
; 112(3): 424-8, 2015 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-25535726
11.
Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment.
Ann Oncol
; 26(4): 731-736, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25628445
12.
Improved Survival with Anti-VEGF Therapy in the Treatment of Unresectable Appendiceal Epithelial Neoplasms.
Ann Surg Oncol
; 22(8): 2578-84, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25582740
13.
Phase II study of saracatinib (AZD0530) in patients with previously treated metastatic colorectal cancer.
Invest New Drugs
; 33(4): 977-84, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26062928
14.
Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR response.
BMC Cancer
; 15: 713, 2015 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-26474549
15.
On the underreporting of health-related quality of life and regulatory approval.
Ann Oncol
; 30(4): 657-658, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30698646
16.
Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer.
Ann Oncol
; 30(3): 495, 2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29982323
17.
Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H).
Ann Oncol
; 25(5): 1032-8, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24585723
18.
Clinicopathologic characteristics and gene expression analyses of non-KRAS 12/13, RAS-mutated metastatic colorectal cancer.
Ann Oncol
; 25(10): 2008-2014, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25009008
19.
A retrospective study of ampullary adenocarcinomas: overall survival and responsiveness to fluoropyrimidine-based chemotherapy.
Ann Oncol
; 24(9): 2349-53, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23704197
20.
Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix.
Ann Oncol
; 23(3): 652-658, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21653683